Waun Ki Hong
Overview
Explore the profile of Waun Ki Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
7060
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu X, Fujimoto J, Ying L, Fukuoka J, Ashizawa K, Sun W, et al.
Nat Commun
. 2021 May;
12(1):2888.
PMID: 33980839
No abstract available.
2.
Hu X, Fujimoto J, Ying L, Fukuoka J, Ashizawa K, Sun W, et al.
Nat Commun
. 2019 Jul;
10(1):2978.
PMID: 31278276
There has been a dramatic increase in the detection of lung nodules, many of which are preneoplasia atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) or...
3.
Ruder D, Papadimitrakopoulou V, Shien K, Behrens C, Kalhor N, Chen H, et al.
Oncotarget
. 2018 Oct;
9(74):33995-34008.
PMID: 30338041
Despite a therapeutic paradigm shift into targeted-driven medicinal approaches, resistance to therapy remains a hallmark of lung cancer, driven by biological and molecular diversity. Using genomic and expression data from...
4.
Saintigny P, William Jr W, Foy J, Papadimitrakopoulou V, Lang W, Zhang L, et al.
J Natl Cancer Inst
. 2018 Apr;
110(3).
PMID: 29617836
Background: We have previously shown that gene expression profiles of oral leukoplakia (OL) may improve the prediction of oral cancer (OC) risk. To identify new targets for prevention, we performed...
5.
Gomez D, Byers L, Nilsson M, Diao L, Wang J, Li L, et al.
Oncotarget
. 2018 Mar;
9(18):14268-14284.
PMID: 29581842
While several molecular targets have been identified for adenocarcinoma (ACA) of the lung, similar drivers with squamous cell carcinoma (SCC) are sparse. We compared signaling pathways and potential therapeutic targets...
6.
Lee W, Diao L, Wang J, Zhang J, Roarty E, Varghese S, et al.
Mod Pathol
. 2018 Feb;
31(6):947-955.
PMID: 29410488
Intra-tumor heterogeneity may be present at all molecular levels. Genomic intra-tumor heterogeneity at the exome level has been reported in many cancer types, but comprehensive gene expression intra-tumor heterogeneity has...
7.
Tsao A, Lin H, Carter B, Lee J, Rice D, Vaporcyan A, et al.
J Thorac Oncol
. 2018 Jan;
13(2):246-257.
PMID: 29313814
Introduction: Window of opportunity trials in malignant pleural mesothelioma (MPM) are challenging but can yield important translational information about a novel agent. Methods: We treated patients with MPM (N =...
8.
Nilsson M, Sun H, Diao L, Tong P, Liu D, Li L, et al.
Sci Transl Med
. 2017 Nov;
9(415).
PMID: 29118262
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) resistance mediated by T790M-independent mechanisms remains a major challenge in the treatment of non-small cell lung cancer (NSCLC). We identified a...
9.
10.
Liu Y, Zhang J, Yin G, Zhang J, Zheng S, Cheung H, et al.
Nat Commun
. 2016 Oct;
7:13200.
PMID: 27767028
Multiple synchronous lung cancers (MSLCs) present a clinical dilemma as to whether individual tumours represent intrapulmonary metastases or independent tumours. In this study we analyse genomic profiles of 15 lung...